Allison Wagreich, MD
Gynecologic Oncology · Morristown, NJNPI 1083855332
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $498, 5.0 times the $100 reported in 2019.
Across 76 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$281
- GSK$244
- AstraZeneca$173
- Mirati Therapeutics, Inc.$153
- Novartis$96
- Johnson & Johnson$70
- plus $511 from 21 others
What the payments were for
- Food & beverage$1,529100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 10 | $281 |
| GSK | 13 | $244 |
| AstraZeneca(2 entities) | 11 | $173 |
| Mirati Therapeutics, Inc. | 9 | $153 |
| Novartis | 6 | $96 |
| Johnson & Johnson(2 entities) | 4 | $70 |
| Kerecis Limited | 1 | $59 |
| Davol Inc. | 1 | $52 |
| Astellas Pharma US Inc | 2 | $41 |
| Caris MPI, Inc. | 1 | $36 |
| Eisai Inc. | 2 | $33 |
| Foundation Medicine, Inc. | 1 | $33 |
| Solventum Corporation | 1 | $22 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Incyte Corporation | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $17 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Tersera Therapeutics LLC | 1 | $17 |
| Sanofi | 1 | $17 |
| Taiho Oncology, Inc. | 1 | $16 |
| AbbVie | 1 | $16 |
| EMD Serono, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Tesaro, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$125
How this compares
$1,529 in reported general payments places this provider in the 55th percentile of 45 gynecologic oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $11,373 |
| Estradiol | 34 | $1,937 |
| Letrozole | 19 | $262 |
| Oxycodone Hcl | 23 | $53 |
| Medroxyprogesterone Acetate | 11 | $39 |
| Tramadol Hcl | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Morristown
- Daniel TobiasMorristown$11K
- Shannon TomitaMorristown$4K
- Nana TchaboMorristown$2K
- Paul HellerMorristown$632
- Sharyn LewinTeaneck$968K
- Scott RichardFlorham Park$84K
- Joyce VarughesePennington$16K
- James BosscherNeptune$13K
- Karim ElsahwiNeptune$11K
- William BurkeParamus$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.